Acumen Pharmaceuticals, Inc. (ABOS)
Total Valuation
ABOS has a market cap or net worth of $222.38 million. The enterprise value is $6.76 million.
Market Cap | 222.38M |
Enterprise Value | 6.76M |
Important Dates
The last earnings date was Monday, November 13, 2023, before market open.
Earnings Date | Nov 13, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
ABOS has 57.91 million shares outstanding. The number of shares has increased by 33.89% in one year.
Shares Outstanding | 57.91M |
Shares Change (YoY) | +33.89% |
Shares Change (QoQ) | +32.19% |
Owned by Insiders (%) | 8.16% |
Owned by Institutions (%) | 83.38% |
Float | 30.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.79 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 35.85, with a Debt / Equity ratio of 0.00.
Current Ratio | 35.85 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.90% and return on invested capital (ROIC) is -20.30%.
Return on Equity (ROE) | -23.90% |
Return on Assets (ROA) | -23.00% |
Return on Capital (ROIC) | -20.30% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.25M |
Employee Count | 39 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.49% in the last 52 weeks. The beta is -0.37, so ABOS's price volatility has been lower than the market average.
Beta (1Y) | -0.37 |
52-Week Price Change | -28.49% |
50-Day Moving Average | 2.68 |
200-Day Moving Average | 4.61 |
Relative Strength Index (RSI) | 74.80 |
Average Volume (30 Days) | 537,258 |
Short Selling Information
The latest short interest is 609,564, so 1.05% of the outstanding shares have been sold short.
Short Interest | 609,564 |
Short Previous Month | 538,295 |
Short % of Shares Out | 1.05% |
Short % of Float | 1.99% |
Short Ratio (days to cover) | 1.19 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -56.90M |
Pretax Income | -48.74M |
Net Income | -48.74M |
EBITDA | -48.55M |
EBIT | -48.74M |
Earnings Per Share (EPS) | -$1.12 |
Balance Sheet
The company has $215.62 million in cash and $2,000 in debt, giving a net cash position of $215.62 million or $3.72 per share.
Cash & Cash Equivalents | 215.62M |
Total Debt | 2,000 |
Net Cash | 215.62M |
Net Cash Per Share | $3.72 |
Equity / Book Value | 280.27M |
Book Value Per Share | 4.84 |
Working Capital | 212.50M |
Cash Flow
In the last 12 months, operating cash flow was -$45.95 million and capital expenditures -$39,000, giving a free cash flow of -$45.99 million.
Operating Cash Flow | -45.95M |
Capital Expenditures | -39,000 |
Free Cash Flow | -45.99M |
FCF Per Share | -$0.85 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ABOS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -21.92% |
FCF Yield | -20.68% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -33.89% |
Shareholder Yield | -33.89% |
Analyst Forecast
The average price target for ABOS is $12.60, which is 228.13% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.60 |
Price Target Difference | 228.13% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | 4.97% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |